UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009864
Receipt number R000011487
Scientific Title Randomized controlled trial to evaluate the clinical efficacy of once- or twice-daily showering for prevention of atopic eczema exacerbation.
Date of disclosure of the study information 2013/01/28
Last modified on 2015/07/24 13:01:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial to evaluate the clinical efficacy of once- or twice-daily showering for prevention of atopic eczema exacerbation.

Acronym

Evaluation of once- or twice-daily showering on atopic eczema.

Scientific Title

Randomized controlled trial to evaluate the clinical efficacy of once- or twice-daily showering for prevention of atopic eczema exacerbation.

Scientific Title:Acronym

Evaluation of once- or twice-daily showering on atopic eczema.

Region

Japan


Condition

Condition

Atopic eczema

Classification by specialty

Clinical immunology Pediatrics Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the difference of clinical efficacy between once- and twice-daily showering for prevention of exacerbation in childhood atopic eczema.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1. The rate of patients without exacerbation.
2. Number of days until the first exacerbation.

Key secondary outcomes

1. Number of weeks with additional application of topical corticosteroid.
2. Caregiver's QOL.
3. Scoring atopic dermatitis. (SCORAD)
4. Patient oriented eczema measure. (POEM)
5. Pruritus and sleeplessness score.
6. Incidence of skin infection.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Once-daily showering

Interventions/Control_2

Twice-daily showering

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Atopic eczema diagnosed with Hanifin & Rajka criteria.
2) Moderate or severe atopic eczema in the recent two years.
3) Applying topical corticosteroid every three or four days to keep good skin condition.
4) Mild eczema or cleared at registration.
5) Showering twice-daily.
6) Pruritus score is two points out of ten or less.

Key exclusion criteria

Taking oral corticosteroids and/or oral immunosuppressive agents.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukihiro Ohya

Organization

National Center for Child Health and Development

Division name

Division of Allergy

Zip code


Address

2-10-1, Okura, Setagaya-ku, Tokyo

TEL

03-3416-0181

Email

ohya-y@ncchd.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukihiro Ohya

Organization

National Center for Child Health and Development

Division name

Division of Allergy

Zip code


Address

2-10-1, Okura, Setagaya-ku, Tokyo

TEL

03-3416-0181

Homepage URL


Email

ohya-y@ncchd.go.jp


Sponsor or person

Institute

National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

National Center for Child Health and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独)国立成育医療研究センター(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 01 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 20 Day

Date of IRB


Anticipated trial start date

2013 Year 01 Month 28 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 05 Month 31 Day

Date trial data considered complete

2015 Year 07 Month 31 Day

Date analysis concluded

2015 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 01 Month 24 Day

Last modified on

2015 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011487


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name